EKF Diagnostics (LON:EKF) Shares Pass Above 200-Day Moving Average – Here’s Why
by Doug Wharley · The Cerbat GemEKF Diagnostics Holdings plc (LON:EKF – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 25.73 and traded as high as GBX 25.90. EKF Diagnostics shares last traded at GBX 24.60, with a volume of 72,517 shares.
EKF Diagnostics Price Performance
The company has a market capitalization of £105.62 million, a PE ratio of 52.13 and a beta of 0.49. The company has a current ratio of 4.16, a quick ratio of 1.77 and a debt-to-equity ratio of 2.01. The stock has a fifty day simple moving average of GBX 24.93 and a 200-day simple moving average of GBX 25.69.
EKF Diagnostics (LON:EKF – Get Free Report) last announced its quarterly earnings results on Tuesday, March 24th. The company reported GBX 0.47 earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%. Equities analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.
EKF Diagnostics Company Profile
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.